BlackRock Investment Management, LLC - BIOSPECIFICS TECHNOLOGIES CO ownership

BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 81 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of BIOSPECIFICS TECHNOLOGIES CO
ValueSharesWeighting
Q4 2016$1,193,000
+23.1%
21,410
+0.9%
0.00%0.0%
Q3 2016$969,000
+13.5%
21,217
-0.8%
0.00%0.0%
Q2 2016$854,000
+38.9%
21,389
+21.2%
0.00%0.0%
Q1 2016$615,000
-16.7%
17,651
+2.8%
0.00%0.0%
Q4 2015$738,000
-1.1%
17,176
+0.2%
0.00%0.0%
Q3 2015$746,000
-17.4%
17,138
-2.1%
0.00%0.0%
Q2 2015$903,000
+111.5%
17,507
+60.6%
0.00%0.0%
Q1 2015$427,000
+4.4%
10,899
+3.0%
0.00%0.0%
Q4 2014$409,000
+9.4%
10,584
+0.0%
0.00%0.0%
Q3 2014$374,000
+37.5%
10,582
+4.7%
0.00%
Q2 2014$272,00010,1050.00%
Other shareholders
BIOSPECIFICS TECHNOLOGIES CO shareholders Q2 2015
NameSharesValueWeighting ↓
JW Asset Management, LLC 73,649$3,646,0002.32%
Stonepine Capital Management, LLC 59,878$2,965,0001.60%
NORTHPOINTE CAPITAL LLC 109,644$5,428,0000.57%
Elk Creek Partners, LLC 145,406$7,199,0000.47%
TFS CAPITAL LLC 18,208$901,0000.35%
RICE HALL JAMES & ASSOCIATES, LLC 161,671$8,004,0000.35%
Ativo Capital Management LLC 19,592$970,0000.26%
Matarin Capital Management, LLC 57,034$2,823,753,0000.26%
ISTHMUS PARTNERS, LLC 16,505$817,0000.24%
Stanley-Laman Group, Ltd. 12,546$621,0000.17%
View complete list of BIOSPECIFICS TECHNOLOGIES CO shareholders